Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tatsuro Tanabe
Intravitreal Aflibercept for Exudative Age-Related Macular Degeneration With Good Visual Acuity: 2-Year Results of a Prospective Study
Clinical Ophthalmology
Ophthalmology
Effective Intravitreal Injections of Bevacizumab in a Case of Serous Macular Detachment From the Superior Border of the Posterior Staphyloma
Case Reports in Ophthalmology
Ophthalmology
Related publications
Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration in Patients Aged 90 Years or Older: 2-Year Visual Acuity Outcomes
Eye
Medicine
Arts
Sensory Systems
Ophthalmology
Humanities
Results of Switchback From Ranibizumab to Aflibercept in Patients With Exudative Age-Related Macular Degeneration
Clinical Ophthalmology
Ophthalmology
One Year Effectiveness Study of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration: A Meta-Analysis
Acta Ophthalmologica
Medicine
Ophthalmology
Aflibercept for Neovascular Age-Related Macular Degeneration
Cochrane Database of Systematic Reviews
Treat-And-Extend Therapy Using Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration: 2-Year Real-World Practice Data From Slovenia
BMC Ophthalmology
Medicine
Ophthalmology
The Efficacy of Intravitreal Aflibercept in Submacular Hemorrhage Secondary to Wet Age-Related Macular Degeneration
Korean journal of ophthalmology : KJO
Medicine
Effect of Intravitreal Injection of Aflibercept on Blood Coagulation Parameters in Patients With Age-Related Macular Degeneration
Therapeutic Advances in Ophthalmology
Effect of Intravitreal Bevacizumab on Visual Acuity and Optical Coherence Tomography (Oct) Changes in Wet Age-Related Macular Degeneration
Journal of Evidence Based Medicine and Healthcare
A Retrospective Analysis of the Effect of Subretinal Hyper-Reflective Material and Other Morphological Features of Neovascular Age-Related Macular Degeneration on Visual Acuity Outcomes in Eyes Treated With Intravitreal Aflibercept Over One Year
Vision (Switzerland)
Ophthalmology
Cognitive Neuroscience
Optometry
Sensory Systems
Cell Biology
